The MAOA gene provides instructions for making an enzyme called monoamine oxidase A. This enzyme is part of a family of enzymes that break down molecules called monoamines through a chemical reaction known as oxidation. Among the monoamines broken down by monoamine oxidase A are certain chemicals that act as neurotransmitters, which transmit signals between nerve cells in the brain. Neurotransmitters are broken down when signaling is no longer needed.
Specifically, monoamine oxidase A is involved in the breakdown of the neurotransmitters serotonin, epinephrine, norepinephrine, and dopamine. Signals transmitted by serotonin regulate mood, emotion, sleep, and appetite. Epinephrine and norepinephrine control the body's response to stress. Dopamine transmits signals within the brain to produce smooth physical movements.
Monoamine oxidase A also helps break down monoamines found in the diet. It seems to be particularly important in the breakdown of excess tyramine, which is found in cheese and other foods.
Monoamine oxidase A appears to be involved in normal brain development before birth. The enzyme plays a role in the controlled self-destruction of cells (apoptosis), which is an important process in the development of many tissues and organs, including the brain.
Health Conditions Related to Genetic Changes
Monoamine oxidase A deficiency
Mutations in the MAOA gene cause monoamine oxidase A deficiency. This condition affects males almost exclusively and is characterized by mild intellectual disability and behavioral problems, including aggressive and violent outbursts. In some cases, particular foods seem to worsen symptoms of the condition. The MAOA gene mutations reduce monoamine oxidase A activity, which causes serotonin and other neurotransmitters to build up in the brain. It is unclear how this buildup leads to the signs and symptoms of monoamine oxidase A deficiency. Researchers speculate that an excess of certain neurotransmitters, particularly serotonin and norepinephrine, may impair an affected individual's ability to control his impulses, leading to aggressive outbursts. Some studies suggest that reduced monoamine oxidase A activity alters development of certain regions of the brain, which may contribute to intellectual disability and behavioral problems in people with monoamine oxidase A deficiency. Researchers suspect that a buildup of tyramine can contribute to the problems associated with the condition, which may be why foods high in this molecule can worsen symptoms.More About This Health Condition
Genetic changes that affect the MAOA gene have been linked to multiple disorders. Some of these genetic changes remove pieces of DNA (deletion mutations) that include the MAOA gene. Deletion mutations that remove both the MAOA gene and the nearby MAOB gene have been found in individuals with severely delayed development of mental and motor skills, weak muscle tone (hypotonia), and repetitive hand movements. Deletion mutations that remove these two genes and another nearby gene called NDP have also been found. The NDP gene is associated with a condition called Norrie disease, which causes blindness and sometimes mild developmental delays and problems with other body systems. Individuals missing the MAOA, MAOB, and NDP genes have severe intellectual disability, difficulty with social interactions (autism spectrum disorders), and seizures in addition to features of Norrie disease. Researchers speculate that loss of the MAOA or MAOB gene underlies the neurological problems in individuals with deletion mutations.
Several common genetic variants (polymorphisms) in or near the MAOA gene have been found to affect the gene's activity. The most studied polymorphism, called MAOA-uVNTR, occurs in an area near the MAOA gene, called the promoter region, that controls gene activity. In this region, a string of 30 DNA building blocks (nucleotides) is repeated, end-to-end, two to five times. Studies show that when the string of nucleotides is repeated 3.5 or four times, more monoamine oxidase A protein is produced than when the nucleotides are repeated only two or three times. For this reason, versions of DNA (alleles) with 3.5 or four repeats are referred to as high-activity alleles. Versions with only two or three repeats, which result in lower than normal amounts of monoamine oxidase A, are considered low-activity alleles. It is unclear what effect five repeats has on MAOA gene activity.
Low-activity MAOA-uVNTR alleles are associated with aggressive behavior. Several reports found the effect only in males, but some other reports indicate that both males and females with low-activity alleles can be prone to aggression. Some studies indicate that low-activity alleles specifically increase the risk of violence and aggression in individuals who were abused as children. Researchers are studying how these MAOA gene polymorphisms are involved in modulating behavior and the role of environmental factors, such as childhood abuse or situations in which a person is provoked.
In contrast, high-activity MAOA-uVNTR alleles appear to increase the risk of panic disorder in females. Panic disorder is a severe anxiety disorder characterized by episodes of overwhelming fear (panic attacks) with no obvious trigger. It is unclear how high amounts of monoamine oxidase A contribute to panic disorder.
Other polymorphisms that can affect MAOA gene activity may also be associated with aggression. The roles of MAOA-uVNTR and other polymorphisms are also being studied in depression, bipolar disorder, alcoholism, drug addiction, and many other conditions.
Other Names for This Gene
- amine oxidase [flavin-containing] A isoform 1
- amine oxidase [flavin-containing] A isoform 2
- monoamine oxidase type A
Additional Information & Resources
Tests Listed in the Genetic Testing Registry
Scientific Articles on PubMed
Catalog of Genes and Diseases from OMIM
- Bach AW, Lan NC, Johnson DL, Abell CW, Bembenek ME, Kwan SW, Seeburg PH, Shih JC. cDNA cloning of human liver monoamine oxidase A and B: molecular basis of differences in enzymatic properties. Proc Natl Acad Sci U S A. 1988 Jul;85(13):4934-8. doi: 10.1073/pnas.85.13.4934. Citation on PubMed or Free article on PubMed Central
- Brunner HG, Nelen M, Breakefield XO, Ropers HH, van Oost BA. Abnormal behavior associated with a point mutation in the structural gene for monoamine oxidase A. Science. 1993 Oct 22;262(5133):578-80. doi: 10.1126/science.8211186. Citation on PubMed
- Caspi A, McClay J, Moffitt TE, Mill J, Martin J, Craig IW, Taylor A, Poulton R. Role of genotype in the cycle of violence in maltreated children. Science. 2002 Aug 2;297(5582):851-4. doi: 10.1126/science.1072290. Citation on PubMed
- Chester DS, DeWall CN, Derefinko KJ, Estus S, Peters JR, Lynam DR, Jiang Y. Monoamine oxidase A (MAOA) genotype predicts greater aggression through impulsive reactivity to negative affect. Behav Brain Res. 2015 Apr 15;283:97-101. doi: 10.1016/j.bbr.2015.01.034. Epub 2015 Jan 28. Citation on PubMed or Free article on PubMed Central
- Godar SC, Bortolato M, Richards SE, Li FG, Chen K, Wellman CL, Shih JC. Monoamine Oxidase A is Required for Rapid Dendritic Remodeling in Response to Stress. Int J Neuropsychopharmacol. 2015 Apr 8;18(9):pyv035. doi: 10.1093/ijnp/pyv035. Citation on PubMed or Free article on PubMed Central
- Grimsby J, Chen K, Wang LJ, Lan NC, Shih JC. Human monoamine oxidase A and B genes exhibit identical exon-intron organization. Proc Natl Acad Sci U S A. 1991 May 1;88(9):3637-41. doi: 10.1073/pnas.88.9.3637. Citation on PubMed or Free article on PubMed Central
- Huang YY, Cate SP, Battistuzzi C, Oquendo MA, Brent D, Mann JJ. An association between a functional polymorphism in the monoamine oxidase a gene promoter, impulsive traits and early abuse experiences. Neuropsychopharmacology. 2004 Aug;29(8):1498-505. doi: 10.1038/sj.npp.1300455. Citation on PubMed
- Kuepper Y, Grant P, Wielpuetz C, Hennig J. MAOA-uVNTR genotype predicts interindividual differences in experimental aggressiveness as a function of the degree of provocation. Behav Brain Res. 2013 Jun 15;247:73-8. doi: 10.1016/j.bbr.2013.03.002. Epub 2013 Mar 13. Citation on PubMed
- Palmer EE, Leffler M, Rogers C, Shaw M, Carroll R, Earl J, Cheung NW, Champion B, Hu H, Haas SA, Kalscheuer VM, Gecz J, Field M. New insights into Brunner syndrome and potential for targeted therapy. Clin Genet. 2016 Jan;89(1):120-7. doi: 10.1111/cge.12589. Epub 2015 Apr 19. Citation on PubMed
- Piton A, Poquet H, Redin C, Masurel A, Lauer J, Muller J, Thevenon J, Herenger Y, Chancenotte S, Bonnet M, Pinoit JM, Huet F, Thauvin-Robinet C, Jaeger AS, Le Gras S, Jost B, Gerard B, Peoc'h K, Launay JM, Faivre L, Mandel JL. 20 ans apres: a second mutation in MAOA identified by targeted high-throughput sequencing in a family with altered behavior and cognition. Eur J Hum Genet. 2014 Jun;22(6):776-83. doi: 10.1038/ejhg.2013.243. Epub 2013 Oct 30. Citation on PubMed or Free article on PubMed Central
- Reif A, Weber H, Domschke K, Klauke B, Baumann C, Jacob CP, Strohle A, Gerlach AL, Alpers GW, Pauli P, Hamm A, Kircher T, Arolt V, Wittchen HU, Binder EB, Erhardt A, Deckert J. Meta-analysis argues for a female-specific role of MAOA-uVNTR in panic disorder in four European populations. Am J Med Genet B Neuropsychiatr Genet. 2012 Oct;159B(7):786-93. doi: 10.1002/ajmg.b.32085. Epub 2012 Aug 22. Citation on PubMed
- Sabol SZ, Hu S, Hamer D. A functional polymorphism in the monoamine oxidase A gene promoter. Hum Genet. 1998 Sep;103(3):273-9. doi: 10.1007/s004390050816. Citation on PubMed
- Saito M, Yamagata T, Matsumoto A, Shiba Y, Nagashima M, Taniguchi S, Jimbo E, Momoi MY. MAOA/B deletion syndrome in male siblings with severe developmental delay and sudden loss of muscle tonus. Brain Dev. 2014 Jan;36(1):64-9. doi: 10.1016/j.braindev.2013.01.004. Epub 2013 Feb 13. Citation on PubMed
- Suarez-Merino B, Bye J, McDowall J, Ross M, Craig IW. Sequence analysis and transcript identification within 1.5 MB of DNA deleted together with the NDP and MAO genes in atypical Norrie disease patients presenting with a profound phenotype. Hum Mutat. 2001 Jun;17(6):523. doi: 10.1002/humu.1140. Citation on PubMed
- Wang CC, Borchert A, Ugun-Klusek A, Tang LY, Lui WT, Chu CY, Billett E, Kuhn H, Ufer C. Monoamine oxidase a expression is vital for embryonic brain development by modulating developmental apoptosis. J Biol Chem. 2011 Aug 12;286(32):28322-30. doi: 10.1074/jbc.M111.241422. Epub 2011 Jun 22. Citation on PubMed or Free article on PubMed Central
- Whibley A, Urquhart J, Dore J, Willatt L, Parkin G, Gaunt L, Black G, Donnai D, Raymond FL. Deletion of MAOA and MAOB in a male patient causes severe developmental delay, intermittent hypotonia and stereotypical hand movements. Eur J Hum Genet. 2010 Oct;18(10):1095-9. doi: 10.1038/ejhg.2010.41. Epub 2010 May 19. Citation on PubMed or Free article on PubMed Central
The information on this site should not be used as a substitute for professional medical care or advice. Contact a health care provider if you have questions about your health.